A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients
Clinical trial NCT00752518 · COMPLETED
Trial details
- NCT number
- NCT00752518
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.